Guiyang Xintian Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 968.7 million compared to CNY 750.18 million a year ago. Revenue was CNY 969.84 million compared to CNY 750.95 million a year ago.

Net income was CNY 100.61 million compared to CNY 74.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.4424 compared to CNY 0.3289 a year ago. Diluted earnings per share from continuing operations was CNY 0.4111 compared to CNY 0.3071 a year ago.